应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02206 新荷花
待上市 11-03 16:00:00
0.000
+0.000
--
最高
0.000
最低
0.000
成交量
0.00
今开
0.000
昨收
0.000
日振幅
0.00%
总市值
0.00
流通市值
0.00
总股本
5,866万
成交额
0.00
换手率
0.00%
流通股本
5,866万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
新荷花赴港IPO:30亿市值“袖珍”发行,全场唯一“裸奔”无基石
新浪证券 · 10-30
新荷花赴港IPO:30亿市值“袖珍”发行,全场唯一“裸奔”无基石
中药饮片龙头新荷花(2206.HK)招股进行时,入场费2553港元
格隆汇 · 10-30
中药饮片龙头新荷花(2206.HK)招股进行时,入场费2553港元
新股招股 | 新荷花今起招股,一手入场费2552.99港元
老虎资讯综合 · 10-30
新股招股 | 新荷花今起招股,一手入场费2552.99港元
新荷花今起招股,预计11月11日挂牌上市,中国第一家中药饮片GMP工厂
独角兽早知道 · 10-30
新荷花今起招股,预计11月11日挂牌上市,中国第一家中药饮片GMP工厂
新荷花(02206)10月30日-11月6日招股 拟全球发售651.73万股H股
智通财经 · 10-30
新荷花(02206)10月30日-11月6日招股 拟全球发售651.73万股H股
四川新荷花中药饮片拟发行6,517,300股H股,进军港股市场
公告速递 · 10-30
四川新荷花中药饮片拟发行6,517,300股H股,进军港股市场
新股快讯:TCM中药饮片供应商02206全球发售,最高发售价每股HK$50.55
公告速递 · 10-30
新股快讯:TCM中药饮片供应商02206全球发售,最高发售价每股HK$50.55
四川新荷花中药饮片股份有限公司启动香港上市 拟发行651.73万股H股 最高募资约3.29亿港元
公告速递 · 10-30
四川新荷花中药饮片股份有限公司启动香港上市 拟发行651.73万股H股 最高募资约3.29亿港元
【IPO追踪】新荷花通过聆讯:行业第二为何只有0.4%份额?
港股解码 · 10-26
【IPO追踪】新荷花通过聆讯:行业第二为何只有0.4%份额?
新股消息 | 新荷花通过港交所聆讯 2025年中药饮片产品收入在中国排名第2位
智通财经 · 10-26
新股消息 | 新荷花通过港交所聆讯 2025年中药饮片产品收入在中国排名第2位
新荷花通过港交所聆讯,四个月利润暴增63.7%,中国第一家中药饮片GMP工厂
独角兽早知道 · 10-26
新荷花通过港交所聆讯,四个月利润暴增63.7%,中国第一家中药饮片GMP工厂
新荷花通过上市聆讯:4个月营收4.3亿,期内利润3388万
雷递网 · 10-25
新荷花通过上市聆讯:4个月营收4.3亿,期内利润3388万
新荷花的第六次IPO努力:贷款支付前投资者回购款,集采产品均价同比降25%
澎湃新闻 · 06-09
新荷花的第六次IPO努力:贷款支付前投资者回购款,集采产品均价同比降25%
中药饮片成IPO钉子户,15年6冲IPO,新荷花为何多次上市未果?
创业最前线 · 05-29
中药饮片成IPO钉子户,15年6冲IPO,新荷花为何多次上市未果?
加载更多
公司概况
公司名称:
新荷花
所属市场:
SEHK
上市日期:
--
主营业务:
四川新荷花中药饮片股份有限公司主要从事中药饮片的生产和销售,产品包括毒性饮片和川产道地饮片,服务于中医院、中医诊所、连锁药店及中成药生产企业。
发行价格:
--
{"stockData":{"symbol":"02206","market":"HK","secType":"STK","nameCN":"新荷花","latestPrice":0,"timestamp":1793692800000,"preClose":0,"halted":7,"volume":0,"delay":0,"floatShares":58655400,"shares":58655400,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"11-03 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794360600000},"marketStatusCode":8,"adr":0,"listingDate":1794326400000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1793669400000,1793678400000],[1793682000000,1793692800000]],"volumeRatio":0,"ipoDetail":{"name":"新荷花","exchange":"SEHK","listingDate":"2026-11-11","sharesOutstanding":65172741,"sharesFloat":65172741,"offerAmount":6517300,"priceRange":"40.20 - 50.55","market":"HK","openProspectusDate":"2026-10-30","openProspectusUrl":"https://ossnoticepdf.iqdii.com/stockdata/notice/02206/2026/2026103000020_c.pdf","purchaseBeginDate":"2026-10-30","purchaseEndDate":"2026-11-06","winningDate":"2026-11-09","currency":"HKD","minPurchaseQuantity":50,"peRate":25.14,"use":"1、约33.4%(或76.7百万港元)将用于扩大中药饮片的产能,升级数字化智能生产系统;\n2、约29.0%(或66.6百万港元)将用于公司的销售及营销活动;\n3、约11.4%(或26.2百万港元)将用于公司的面向消费者业务;\n4、约10.2%(或23.4百万港元)将用于在越南及马来西亚建立海外销售渠道;\n5、约6.0%(或13.8百万港元)将用于战略性投资及潜在收购;\n6、约10.0%(或23.0百万港元)将用于营运资金及其他一般公司用途。","industryId":"204005","industryName":"医疗保健","business":"公司是中国的一家大型中药饮片产品供应商。公司制定并实施中医药生产和质量控制的严苛标准,并将数字技术整合至公司的生产和质量控制流程。公司为广泛的机构和零售客户提供服务-包括医院及医疗机构、医疗贸易公司、药店、制药公司及最近的个人消费者-提供传统草药配方、健康产品和健康管理服务。","subscribed":4.08,"marketCap":2620000000,"minimumCapital":2552.99,"overAllotment":false,"lotSize":50,"issueOpenRate":0.1,"subscribeGear":"50,100,150,200,250,300,350,400,450,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,325850","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-11-10","greyDateTimestamp":1794240000000,"greyOpeningTime":1794298500000,"greyClosingTime":1794306600000,"showGreyQuote":false,"openProspectusDate":"2026-10-30","listingDate":"2026-11-11"},"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02206","defaultTab":"news","newsList":[{"id":"2679297632","title":"新荷花赴港IPO:30亿市值“袖珍”发行,全场唯一“裸奔”无基石","url":"https://stock-news.laohu8.com/highlight/detail?id=2679297632","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679297632?lang=zh_cn&edition=full","pubTime":"2026-10-30 18:35","pubTimestamp":1793356500,"startTime":"0","endTime":"0","summary":"10月30日,港股市场迎来了久违的IPO小高峰,共有6家公司同日启动招股,另有1家介绍上市。无基石背后的定价难题回到本次IPO的发行结构。在近期大型IPO项目普遍能锁定30%-50%基石的市场环境下,新荷花的“零基石”,使其上市首日的表现将完全暴露在散户情绪和当下疲软的流动性环境之下。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-10-30/doc-iniwzazq5500167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","BK4127","REDS","FRHC","02206","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679986082","title":"中药饮片龙头新荷花(2206.HK)招股进行时,入场费2553港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679986082","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679986082?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:34","pubTimestamp":1793349248,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["EWH","IPOS","02206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176431803","title":"新股招股 | 新荷花今起招股,一手入场费2552.99港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176431803","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176431803?lang=zh_cn&edition=full","pubTime":"2026-10-30 10:18","pubTimestamp":1793326703,"startTime":"0","endTime":"0","summary":"10月30日,新荷花发布公告,公司拟全球发售651.73万股H股,其中,香港公开发售中初步提呈发售65.175万股H股;国际发售中初步提呈发售586.555万股H股;2026年10月30日至11月6日招股,预期定价日为11月9日;发售价将为每股发售股份40.20港元-50.55港元,每手买卖单位将为50股,广发证券及农银国际为联席保荐人;预期H股将于2026年11月11日开始于联交所买卖。假设发售价为每股H股45.38港元,公司估计将收到的全球发售所得款项净额约为2.297亿港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3430ee0e05254278b5a3da84a7b77b4c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股招股 | 新荷花今起招股,一手入场费2552.99港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679567372","title":"新荷花今起招股,预计11月11日挂牌上市,中国第一家中药饮片GMP工厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2679567372","media":"独角兽早知道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679567372?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:33","pubTimestamp":1793320380,"startTime":"0","endTime":"0","summary":"新荷花的竞争抓手,首先建立在“标准化”上。截至2026年4月30日,委聘了20名GAP认证供应商,涉及23个基地,总面积约29.7平方公里。新荷花的药店渠道收入从2023年的2.38亿元一路下滑至2024年的2.11亿元、2025年的1.79亿元。对冲药店失血的,是全国中药饮片集采带来的医院端放量。2025年2月第一轮集采中,新荷花中标29个品种、55种规格;1302家公立医院选择其产品,其中1217家为全新客户。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU3MTY1MzExOQ==&mid=2247615184&idx=4&sn=aba18002f64fe3a2d8813287c082c349&chksm=fd57de1c74f56fac9b4e47ad39f514dd183a2af7154ab900ebf9798121c6eea7b320ac5f4de4&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","02206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679253646","title":"新荷花(02206)10月30日-11月6日招股 拟全球发售651.73万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679253646","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679253646?lang=zh_cn&edition=full","pubTime":"2026-10-30 07:48","pubTimestamp":1793317708,"startTime":"0","endTime":"0","summary":"于往绩记录期间,集团的收入由2023年的人民币11.46亿元增至2025年的人民币13.35亿元,同年毛利由人民币2.12亿元增至人民币2.53亿元。此外,集团的收入由截至2025年4月30日止四个月的人民币3.83亿元增至截至2026年4月 30日止四个月的人民币4.32亿元,同期毛利由人民币7220万元增至人民币9420万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02206","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106263442","title":"四川新荷花中药饮片拟发行6,517,300股H股,进军港股市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1106263442","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106263442?lang=zh_cn&edition=full","pubTime":"2026-10-30 06:32","pubTimestamp":1793313147,"startTime":"0","endTime":"0","summary":"本次全球发售合计6,517,300股H股,其中香港公开发售部分初步拟发行651,750股,其余5,865,550股通过国际配售完成。完成发行并将原有内资股份转换为H股后,公司总股本将由58,655,441股增至65,172,741股,预计新发行股份占发行后总股本的10%。根据已披露资料,若发售价假设为每股45.38港元,预计全球发售所得款项净额约为2.297亿港元;如发售价提升至50.50港元,则该净额将再增加约3,220万港元。本次全球发售如顺利完成,四川新荷花中药饮片将在港交所主板上市。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"四川新荷花中药饮片拟发行6,517,300股H股,进军港股市场","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111804796","title":"新股快讯:TCM中药饮片供应商02206全球发售,最高发售价每股HK$50.55","url":"https://stock-news.laohu8.com/highlight/detail?id=1111804796","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111804796?lang=zh_cn&edition=full","pubTime":"2026-10-30 06:29","pubTimestamp":1793312944,"startTime":"0","endTime":"0","summary":"公司主要通过向医院、医疗机构、医药公司、药房及医药贸易商销售逾770种、约4,900个品规的中药饮片来获得收入,并在数字化平台方面积极布局。2023年至2025年,公司收入分别约为人民币11.46亿元、12.49亿元及13.35亿元,四个月与分别实现收入约3.83亿元及4.32亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股快讯:TCM中药饮片供应商02206全球发售,最高发售价每股HK$50.55","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170088235","title":"四川新荷花中药饮片股份有限公司启动香港上市 拟发行651.73万股H股 最高募资约3.29亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170088235","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170088235?lang=zh_cn&edition=full","pubTime":"2026-10-30 06:10","pubTimestamp":1793311857,"startTime":"0","endTime":"0","summary":"2026年10月30日,四川新荷花中药饮片股份有限公司公布全球发售详情,计划在香港联交所主板挂牌上市,预期股份于2026年11月11日正式开始买卖,每手50股,股份代号为02206。发售价区间为每股40.20港元至50.55港元;以最高发售价计算,募资规模可达约3.29亿港元。本次香港公开发售采取全电子化申购,不提供纸质招股章程及书面申请表。根据公告,新荷花的招股章程电子版已刊载于香港联交所及公司官网,有意投资者须在阅读相关文件后审慎作出投资决定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678712686","title":"【IPO追踪】新荷花通过聆讯:行业第二为何只有0.4%份额?","url":"https://stock-news.laohu8.com/highlight/detail?id=2678712686","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678712686?lang=zh_cn&edition=full","pubTime":"2026-10-26 16:10","pubTimestamp":1793002200,"startTime":"0","endTime":"0","summary":"新荷花此前并非首次接触资本市场。01“行业第二”有分量,但0.4%的份额更能说明竞争现实新荷花成立于2001年12月,2009年改制为股份有限公司,主要从事中药饮片研发、生产及销售。2026年,第二轮中药集采覆盖41个品种中药饮片,其中公司有40个品种中标。在聆讯资料中,新荷花表示第二轮中药集采尚未给公司产生任何收入。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI2MDAzMTQ4OA==&mid=2650514561&idx=2&sn=2db657203d57f58a1cc6bf5654cbb2d2&chksm=f3f50807040da9a96463252dc2bbd14a89af4501da22d3b2f0f7355ee4c2219b8b3571993609&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678534521","title":"新股消息 | 新荷花通过港交所聆讯 2025年中药饮片产品收入在中国排名第2位","url":"https://stock-news.laohu8.com/highlight/detail?id=2678534521","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678534521?lang=zh_cn&edition=full","pubTime":"2026-10-26 11:10","pubTimestamp":1792984229,"startTime":"0","endTime":"0","summary":"根据弗若斯特沙利文的资料,按2025年中药饮片产品收入计算,新荷花在中国排名第2位,在竞争激烈的市场格局中占据0.4%的市场份额,而前五大市场参与者合共持有2.7%的市场份额。截至最后实际可行日期,新荷花提供超过770种及4,900个品种的中药饮片产品,涵盖中医药行业使用的所有主要药材。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512191.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678412665","title":"新荷花通过港交所聆讯,四个月利润暴增63.7%,中国第一家中药饮片GMP工厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2678412665","media":"独角兽早知道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678412665?lang=zh_cn&edition=full","pubTime":"2026-10-26 09:01","pubTimestamp":1792976460,"startTime":"0","endTime":"0","summary":"公司整体毛利率从2023年的18.5%降至2024年的17.1%后,2025年回升至19.0%,2026年前四个月进一步攀升至21.8%。2025年2月,全国45种中药饮片第一轮集采结果公布,新荷花中标29个品种共55种规格,共有1302家公立医院选择其产品,累计中标合同金额达3290万元,其中1217家为新客户。新荷花的业绩增长,与其核心大单品的销量波动息息相关。通过港交所聆讯,是新荷花走向公开市场的关键一步。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU3MTY1MzExOQ==&mid=2247615005&idx=1&sn=a9479edbed4cb76ee2dd6a4e4793fa85&chksm=fd10c4f5779feebad126f76955ea890ee73b148b2e4c21443498a3e23691645f11cad44278e7&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678358721","title":"新荷花通过上市聆讯:4个月营收4.3亿,期内利润3388万","url":"https://stock-news.laohu8.com/highlight/detail?id=2678358721","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678358721?lang=zh_cn&edition=full","pubTime":"2026-10-25 23:09","pubTimestamp":1792940990,"startTime":"0","endTime":"0","summary":"四川新荷花中药饮片股份有限公司(简称:“新荷花”)日前通过上市聆讯,准备在港交所上市。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261025/6392856651918625022430414.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261025/6392856651918625022430414.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35488/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["02206","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642462018","title":"新荷花的第六次IPO努力:贷款支付前投资者回购款,集采产品均价同比降25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642462018","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642462018?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:50","pubTimestamp":1781005828,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/KV0NSS7R0514R9P4.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/KV0NSS7R0514R9P4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02206"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639662003","title":"中药饮片成IPO钉子户,15年6冲IPO,新荷花为何多次上市未果?","url":"https://stock-news.laohu8.com/highlight/detail?id=2639662003","media":"创业最前线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639662003?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:57","pubTimestamp":1780059420,"startTime":"0","endTime":"0","summary":"时隔八年,新荷花于2020年9月再次向深交所创业板递交招股书,试图在注册制改革的东风下重启上市之路。2021年4月,新荷花以“考虑当时市场条件”为由,主动撤回了第二次A股上市申请。2025年4月3日,新荷花首次向港交所递交招股书,六个月后未获进展而自动失效;2025年10月17日,公司第二次递表,时隔六个月再次遭遇招股书失效。2023年至2025年,新荷花毛利率分别为18.5%、17.1%、19.0%。不过,随后出现了“举报门”事件,公司的上市议程也被搁置。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-05-29/doc-inhzqptf9390307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02206","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xinhehua.com/","compareEarnings":[{"period":"1week","weight":0.0078},{"period":"1month","weight":-0.0242},{"period":"3month","weight":-0.0951},{"period":"6month","weight":-0.1076},{"period":"1year","weight":-0.097},{"period":"ytd","weight":-0.0873}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"四川新荷花中药饮片股份有限公司主要从事中药饮片的生产和销售,产品包括毒性饮片和川产道地饮片,服务于中医院、中医诊所、连锁药店及中成药生产企业。","exchange":"SEHK","name":"新荷花","nameEN":"NEAUTUS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新荷花(02206)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新荷花(02206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新荷花,02206,新荷花股票,新荷花股票老虎,新荷花股票老虎国际,新荷花行情,新荷花股票行情,新荷花股价,新荷花股市,新荷花股票价格,新荷花股票交易,新荷花股票购买,新荷花股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新荷花(02206)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新荷花(02206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}